Stop Buying Software.
Hire Your Digital Director.
ARIA.Autonomous Reasoning & Intelligence AgentThe first intelligence engine for Biotech that perceives clinical signals, orients strategy, and acts. 24/7.
ARIA
DIGITAL DIRECTOR
Your Team is
Drowning.
Life sciences commercial teams spend 72% of their time on administrative work—CRM updates, pipeline reviews, competitive research. Only 28% is spent actually selling.
ARIA is your workforce multiplier. She executes the high-stakes strategic work of an elite Director—pre-meeting research, competitive intelligence, market signals—with executive-grade precision, reclaiming the selling hours your revenue deserves.
57%
Reps Missing Quota
$176B
Patent Cliff at Risk
Market Intelligence
100% Autonomous
Pre-Meeting Research
Active Intelligence
Competitive Battle Cards
Auto-Updated
Admin Burden
0% Human-Required
$8M
Daily cost of clinical trial delays for top-tier Life Science assets.
The ChatGPT Ban
Was Right.
65% of the Top 20 Biotech companies have banned public AI. They didn't ban the intelligence—they banned the vulnerability.
ARIA is the exception. Built on an architecture of In Silico Sovereignty, your proprietary molecular data and clinical strategy never touch public models. Single-tenant isolation is not a feature; it's our foundation.
Why Now.
Multiple forcing functions are converging to create unprecedented demand for AI-powered commercial intelligence in life sciences.
AI Capability
Large language models have finally reached the sophistication required for complex commercial reasoning and autonomous execution.
Enterprise Demand
65% of pharma banned ChatGPT—creating massive pent-up demand for secure, vertical AI that respects data sovereignty.
Cost Pressure
Industry-wide layoffs mean commercial teams must do more with fewer people. Efficiency is no longer optional.
Patent Cliff
$176B in revenue at risk through 2029 creates unprecedented pressure to maximize every commercial interaction.
Infrastructure Ready
Modern integration protocols enable rapid connection to enterprise systems—CRM, collaboration, and productivity tools.
First-Mover Window
Horizontal AI players will eventually go vertical. The window to establish domain expertise advantage is measured in months, not years.
The Window is
Closing.
With $176B in patent cliff revenue at risk through 2029, every commercial team is under pressure to do more with less. ARIA monitors 500,000+ clinical trials and market signals in real-time to find the opportunities others miss.
28%
Time Selling
The rest? Lost to CRM updates, pipeline reviews, and admin work.
8-11mo
Rep Ramp Time
New hires take nearly a year to reach full productivity.
65%
Banned ChatGPT
Top pharma companies created massive pent-up demand for secure AI.
$176B
Patent Cliff
Revenue at risk 2026-2029. Pressure to maximize every rep's output.
One Intelligence.
Infinite Roles.
"ARIA isn't software you use. She's a colleague you lead and a mentor to her agentic team."
Strategic Growth
Director of M&A
ARIA hunts for distressed Phase II assets, triangulates patent cliffs, and de-risks acquisition targets before they hit the open market.
Skills Mastery
Expert in: Apollo, Crunchbase, Patent Databases
Trial Acceleration
Director of Clinical Ops
She monitors 500,000+ global trials in real-time, scouting high-performance site activation candidates and flagging enrollment risks.
Skills Mastery
Expert in: ClinicalTrials.gov, Veeva Vault, Medidata
Market Mastery
Director of Commercial Strategy
ARIA automates HCP lead scoring and competitive intel, pushing boardroom-grade market entry strategies directly into your CRM.
Skills Mastery
Expert in: Salesforce, Veeva, LinkedIn Sales Nav
Mastered Skills
Clinical Intelligence
ARIA monitors over 500,000 global clinical trials in real-time, detecting enrollment risks and site activation opportunities before they impact your timeline.
Native Integrations
Proprietary Cognitive
Architecture
ARIA utilizes a proprietary agentic stack designed specifically for the high-stakes requirements of Life Science, combining deep domain logic with autonomous execution.
Sovereign Governance
An autonomous audit layer that validates every strategic pivot and clinical signal against your organization's unique institutional intelligence—ensuring zero-drift execution.
Pipeline Intelligence Percentile
Sovereign Performance
Global Leadership Position
Perpetual Recon
ARIA continuously monitors 500k+ global trials and 20k+ programs via 15+ proprietary scientific data sources—spanning literature, clinical, regulatory, chemical, and patent intelligence—surfacing asymmetric insights before they manifest in public discourse.
Strategic Signal Monitor
A high-fidelity monitoring system of the global biotech landscape. ARIA detects clinical shifts, patent expiration trajectories, and M&A signals with sub-second latency.
Clinical Signal: Oncology
Patent Expiry: Immunology
Competitor M&A: Rare Dis.
Sovereign Integration
Proprietary real-time syncing with 500+ enterprise applications—CRM, collaboration, and productivity tools. Your data remains isolated, secure, and under your absolute control.
Ecosystem Intelligence
Search 50+ Enterprise Apps
Zero-Knowledge Retrieval
Privacy Preserved Sync
Molecular Sync Protocol
Bi-Directional Data Integrity
Optimized Orchestration
Autonomous routing to high-efficiency sub-agents based on task complexity.
Self-Learning Engine
Continuous logic improvement based on organizational feedback loops.
Institutional Memory
Long-term episodic and procedural memory that evolves with your firm.
Multi-Agent Hierarchy
Secure collaboration with granular, role-based permission controls.
Strategic Synthesis
Compressing millions of data points into boardroom-ready intelligence.
Predictive Modeling
Forecasting clinical and commercial outcomes with high-fidelity simulations.
The era of
software is over.
ARIA is here.
Stop buying tools that require more work. Deploy the intelligence that does the work for you. The most innovative Life Science teams are already scaling. Will you?